Yahoo Malaysia Web Search

Search results

  1. Learn about BMS's innovative medicines for serious diseases, ESG report, cell therapy research, and more. Find clinical trials, medical information, and help paying for your medicines.

    • Patients & Caregivers

      At Bristol Myers Squibb, we are committed to helping you get...

    • Healthcare Providers

      Bristol Myers Squibb provides information and resources to...

    • Researchers

      Bristol Myers Squibb wishes to advance science through...

    • Investors

      Forward-looking statements contained on this website should...

    • Business Development

      As a leading biopharma company, partnering is a key priority...

    • News

      Welcome to our newsroom - get access to information and...

    • About Us

      We promote health equity and seek to improve the health...

    • Medicines

      Bristol Myers Squibb focuses on developing new medicines to...

  2. The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.

  3. Learn about BMS's mission, values, leadership, and achievements in discovering and delivering innovative medicines for serious diseases. Explore BMS's sustainability, inclusion, responsibility, and community initiatives.

  4. Find out the names and indications of the company's marketed products for U.S. residents. Learn more about the R&D investment, side effect reporting and legacy brands of Bristol Myers Squibb.

  5. Join BMS and work on life-changing therapies for serious diseases. Explore career areas, benefits, stories, and opportunities for students and contractors.

  6. Feb 2, 2023 · Bristol Myers Squibb posted revenues of $11.4 billion, a decrease of 5%, driven by recent LOE products (primarily Revlimid) and foreign exchange impacts, partially offset by in-line products (primarily Opdivo) and our new product portfolio (primarily Opdualag and Abecma). When adjusted for foreign exchange, revenues decreased 1%.

  7. Jun 21, 2024 · Bristol Myers Squibb Receives European Medicines Agency Validation of Application for Opdivo (nivolumab) plus Yervoy (ipilimumab) for First-Line Treatment of Unresectable or Advanced Hepatocellular Carcinoma

  1. People also search for